GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Adipoq | affects expression | EXP | | 6480464 | CTD | sodium arsenite affects the expression of ADIPOQ; sodium arsenite affects the expression of ADIPOQ mRNA | PMID:25367288 PMID:28206643 | Adipoq | decreases expression | EXP | | 6480464 | CTD | sodium arsenite results in decreased expression of ADIPOQ mRNA; sodium arsenite results in decreased expression of ADIPOQ protein | PMID:29755549 PMID:34968464 | Adipoq | increases expression | EXP | | 6480464 | CTD | sodium arsenite results in increased expression of ADIPOQ mRNA; sodium arsenite results in increased expression of ADIPOQ protein | PMID:28593471 PMID:31170414 | Adipoq | multiple interactions | EXP | | 6480464 | CTD | [Palmitic Acid co-treated with sodium arsenite] results in decreased expression of ADIPOQ mRNA; [Palmitic Acid co-treated with sodium arsenite] results in decreased expression of and results in decreased secretion of ADIPOQ protein; [sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of ADIPOQ mRNA; [sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of and results in decreased secretion of ADIPOQ protein; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of ADIPOQ mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of ADIPOQ protein; Palmitic Acid inhibits the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased secretion of ADIPOQ protein]; sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; sodium arsenite inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein]; sodium arsenite inhibits the reaction [Palmitic Acid results in increased expression of ADIPOQ protein]; sodium arsenite promotes the reaction [Dietary Fats results in increased expression of ADIPOQ protein]; sodium arsenite results in decreased expression of and results in decreased secretion of ADIPOQ protein | PMID:23152186 PMID:28593471 PMID:29755549 PMID:34968464 | Adipoq | decreases expression | ISO | ADIPOQ (Homo sapiens) | 6480464 | CTD | sodium arsenite results in decreased expression of ADIPOQ mRNA | PMID:23650128 PMID:37956786 | Adipoq | multiple interactions | ISO | ADIPOQ (Homo sapiens) | 6480464 | CTD | BQ 610 affects the reaction [sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]]; Pertussis Toxin inhibits the reaction [sodium arsenite results in decreased expression of ADIPOQ mRNA]; RES 701-1 affects the reaction [sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]]; sodium arsenite affects the reaction [Pertussis Toxin promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]]; sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA] | PMID:23152186 PMID:23650128 | |
Go Back to source page | Continue to Ontology report |